CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo

Media coverage

• Title	CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo
  Media name/outlet	Dove Medical Press
  Country/Territory	United Kingdom
  Date	18/12/24
  URL	https://www.dovepress.com/crispr-cas13a-targeting-the-fgfr3-tacc3-fusion-gene-inhibits-prolifera-peer-reviewed-fulltext-article-OTT
  Persons	Matthew Bradley